$31.99 0.00 (0%)
2/13/2012 4:00 PM

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar jvgarrison (59.38) Submitted: 6/14/2008 12:39:14 PM : Outperform Start Price: $16.70 BMY Score: +88.53

Another profitable company with a much above average dividend, and a potential takeover target due to its strong pipeline.

Report this Post Add Comment

Featured Broker Partners


Advertisement